Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing
暂无分享,去创建一个
Lucie Abeler-Dörner | David Bonsall | Luca Ferretti | Chris Wymant | Michelle Kendall | Lele Zhao | Anel Nurtay | Michael Parker | Christophe Fraser | C. Fraser | A. Nurtay | M. Kendall | C. Wymant | Lele Zhao | L. Ferretti | Michael J Parker | D. Bonsall | Lucie Abeler-Dörner
[1] Weizhong Yang,et al. COVID-19 control in China during mass population movements at New Year , 2020, The Lancet.
[2] Christophe Fraser,et al. The Effectiveness of Contact Tracing in Emerging Epidemics , 2006, PloS one.
[3] P. Klepac,et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts , 2020, The Lancet Global Health.
[4] Q. Pham,et al. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam , 2020, The New England journal of medicine.
[5] Yongsheng Wu,et al. Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts , 2020, medRxiv.
[6] C. Dolea,et al. World Health Organization , 1949, International Organization.
[7] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[8] N. Linton,et al. Serial interval of novel coronavirus (2019-nCoV) infections , 2020, medRxiv.
[9] Yungang He,et al. Age-Dependent Risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China , 2020, Frontiers in Medicine.
[10] P ? ? ? ? ? ? ? % ? ? ? ? , 1991 .
[11] G. Chowell,et al. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[12] Yongsheng Wu,et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study , 2020, The Lancet Infectious Diseases.
[13] C. Faes,et al. Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[14] Zhiyuan Luo,et al. On the Feasibility of Using Two Mobile Phones and WLAN Signal to Detect Co-Location of Two Users for Epidemic Prediction , 2014, LBS.
[15] G. Kampf,et al. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents , 2020, Journal of Hospital Infection.
[16] Jon Crowcroft,et al. EpiMap: Towards quantifying contact networks for understanding epidemiology in developing countries , 2014, Ad Hoc Networks.
[17] Moran Ki,et al. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea , 2020, Epidemiology and health.
[18] J. Sung,et al. The epidemiology of the outbreak of severe acute respiratory syndrome (SARS) in Hong Kong – what we do know and what we don't , 2004, Epidemiology and Infection.
[19] Christl A. Donnelly,et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.
[20] Hannah R. Meredith,et al. The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application , 2020 .
[21] C. Whittaker,et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.
[22] G. Wong,et al. SARS-CoV-2 Infection in Children , 2020, The New England journal of medicine.
[23] Christl A. Donnelly,et al. SARS-CoV Antibody Prevalence in All Hong Kong Patient Contacts , 2004, Emerging infectious diseases.
[24] C. Whittaker,et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand , 2020 .
[25] N. Grassly,et al. Mathematical models of infectious disease transmission , 2008, Nature Reviews Microbiology.
[26] Y. Li,et al. Role of air distribution in SARS transmission during the largest nosocomial outbreak in Hong Kong. , 2005, Indoor air.
[27] D. J. Weber,et al. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination☆ , 2015, Journal of Hospital Infection.
[28] Yiu Chung Lau,et al. Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.
[30] L. Yang,et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak , 2020, International Journal of Infectious Diseases.
[31] Z. Tong,et al. Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020 , 2020, Emerging infectious diseases.
[32] M. Baguelin,et al. Report 4: Severity of 2019-novel coronavirus (nCoV) , 2020 .
[33] C. Fraser,et al. Factors that make an infectious disease outbreak controllable. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[34] Chen Shen,et al. ข้อสรุปจากบทความ “ผลของมาตรการที่ไม่ใช่ยาในการลดอัตราการตายและความต้องการทรัพยาการทาง สาธารณสุขเนื่องจากโรคโควิด-19” โดย Neil Ferguson และคณะ Review of Ferguson et al ”Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand.” , 2020 .
[35] Kexin Yang,et al. Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019‐nCoV , 2020, Journal of evidence-based medicine.
[36] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.
[37] Chris Wymant,et al. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing , 2020, medRxiv.
[38] Christel Faes,et al. Estimating the generation interval for COVID-19 based on symptom onset data , 2020, medRxiv.
[39] Caroline O. Buckee,et al. Comparing nonpharmaceutical interventions for containing emerging epidemics , 2017, Proceedings of the National Academy of Sciences.
[40] P. Vollmar,et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany , 2020, The New England journal of medicine.
[41] Malik Peiris,et al. Viral dynamics in mild and severe cases of COVID-19 , 2020, The Lancet Infectious Diseases.
[42] Yan Bai,et al. Presumed Asymptomatic Carrier Transmission of COVID-19. , 2020, JAMA.
[43] Maria A. Kazandjieva,et al. A high-resolution human contact network for infectious disease transmission , 2010, Proceedings of the National Academy of Sciences.
[44] Oon Tek Ng,et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. , 2020, JAMA.
[45] Chee Fu Yung,et al. A Well Infant With Coronavirus Disease 2019 With High Viral Load , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] Tsuyoshi Murata,et al. {m , 1934, ACML.